Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 3
1987 7
1988 40
1989 44
1990 42
1991 53
1992 52
1993 61
1994 73
1995 67
1996 89
1997 83
1998 65
1999 87
2000 81
2001 76
2002 120
2003 90
2004 146
2005 151
2006 154
2007 158
2008 177
2009 182
2010 224
2011 236
2012 229
2013 254
2014 294
2015 346
2016 335
2017 317
2018 324
2019 329
2020 373
2021 385
2022 403
2023 380
2024 288
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,037 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Lymphocytic Leukemia.
Chiorazzi N, Chen SS, Rai KR. Chiorazzi N, et al. Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):a035220. doi: 10.1101/cshperspect.a035220. Cold Spring Harb Perspect Med. 2021. PMID: 32229611 Free PMC article. Review.
Initial therapy of chronic lymphocytic leukemia.
Eichhorst B, Cramer P, Hallek M. Eichhorst B, et al. Semin Oncol. 2016 Apr;43(2):241-50. doi: 10.1053/j.seminoncol.2016.02.005. Epub 2016 Feb 9. Semin Oncol. 2016. PMID: 27040702 Review.
Special volume "Chronic Lymphocytic Leukemia".
Castro JE. Castro JE. Best Pract Res Clin Haematol. 2016 Mar;29(1):1. doi: 10.1016/j.beha.2016.08.012. Epub 2016 Aug 17. Best Pract Res Clin Haematol. 2016. PMID: 27742063 No abstract available.
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Ferrant E, Wierda WG, Munugalavadla V, Yu T, Wang MH, Byrd JC. Sharman JP, et al. Leukemia. 2022 Apr;36(4):1171-1175. doi: 10.1038/s41375-021-01485-x. Epub 2022 Jan 1. Leukemia. 2022. PMID: 34974526 Free PMC article. No abstract available.
Chronic lymphocytic leukemia.
Hallek M, Pflug N. Hallek M, et al. Ann Oncol. 2010 Oct;21 Suppl 7:vii154-64. doi: 10.1093/annonc/mdq373. Ann Oncol. 2010. PMID: 20943609 Free article. Review.
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Siddiqi T, Maloney DG, Kenderian SS, Brander DM, Dorritie K, Soumerai J, Riedell PA, Shah NN, Nath R, Fakhri B, Stephens DM, Ma S, Feldman T, Solomon SR, Schuster SJ, Perna SK, Tuazon SA, Ou SS, Papp E, Peiser L, Chen Y, Wierda WG. Siddiqi T, et al. Lancet. 2023 Aug 19;402(10402):641-654. doi: 10.1016/S0140-6736(23)01052-8. Epub 2023 Jun 6. Lancet. 2023. PMID: 37295445 Clinical Trial.
CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings.
Todorovic Z, Todorovic D, Markovic V, Ladjevac N, Zdravkovic N, Djurdjevic P, Arsenijevic N, Milovanovic M, Arsenijevic A, Milovanovic J. Todorovic Z, et al. Curr Oncol. 2022 May 18;29(5):3647-3657. doi: 10.3390/curroncol29050293. Curr Oncol. 2022. PMID: 35621683 Free PMC article. Review.
6,037 results